Alofanib

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameAlofanib
Drug Alias NameRPT-835
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 2 antagonists
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRussian Pharmaceutical Technologies Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRussian Pharmaceutical Technologies Llc
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A